Life sciences span a wide range of disciplines that study living organisms in six categories, from molecules and cells to ecosystems and human health. The category that intersects in our world is Applied Life Sciences. And more specifically these fields that translate biological knowledge into practical solutions.
- Biotechnology – using living systems for technology and innovation
- Pharmacology – drug action and development
- Biomedical Science – disease mechanisms, diagnostics, therapeutics
- Stem Cell Biology & Regenerative Medicine – cell-based therapies
In this monthly report you will find news and highlights in the Applied Life Sciences.
Biotechnology
Portable TB test matches lab accuracy in just minutes
Drugs to treat tuberculosis have been around for more than 75 years, yet it remains the world’s top infectious disease killer. A big obstacle has been testing. It’s either inaccurate — missing up to half of all cases — or requires expensive laboratories that are not widely available in the countries where most people with TB live. This could change with the arrival of a portable device called MiniDock MTB that can deliver accurate test results in less than half an hour.
BD and Suttons Creek Partner to Help Pharma and Biotech Companies Deliver Combination Products to Market with Confidence
BD (Becton, Dickinson and Company), a global medical technology company, and Suttons Creek, a BlueRidge Life Sciences company, announced a strategic, non-exclusive collaboration designed to help pharmaceutical and biotech companies more efficiently navigate the engineering, testing, quality and regulatory complexity associated with combination product development.
Crown Bioscience and Turbine Partner to Connect AI-Driven Prediction with Organoid Validation in Translational Oncology
Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, announced a strategic partnership with Turbine, a leading virtual biology company, to advance translational oncology research by integrating Turbine’s in silico Virtual Assays with its Tumor Organoid Assays based on HUB Organoid Technology. This collaboration establishes a connected workflow that enables researchers to move more efficiently from hypothesis to validation.
Pharmacology
BioMed X and Servier Launch First Research Team in France to Pioneer AI-Driven Antibody Engineering
BioMed X, an innovation hub for pharma, has officially launched its first research team at BioMed X France, marking the establishment of its presence in one of Europe’s fastest-growing life science ecosystems. The new team, Team ADB (AI-Empowered Design of Bispecific Antibodies), is based within the XSeed Labs incubator on the R&D campus of Servier in Paris-Saclay and hosted at the Spartners facility operated by Servier and BioLabs.
Biomedical
U.S. FDA Grants Breakthrough Device Designation to Laguna Diagnostics’ mRNA Gene Biomarker Test to Aid in Differentiation of Schizophrenia and Bipolar I Disorder
Laguna Diagnostics, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the company’s mRNA Gene Biomarker Test, a novel blood-based test designed to aid in the differentiation of schizophrenia and bipolar I disorder in symptomatic patients.
AOP Health and VRG Therapeutics Enter Co-Development Partnership for New Immunology Program
AOP Health, a global pharmaceutical enterprise group focused on integrated therapies for rare diseases and critical care, announced a strategic partnership with VRG Therapeutics, an AI-driven developer for miniproteins based in Budapest. The collaboration aims to advance a novel Kv1.3 potassium channel inhibitor, a key regulator of immune cell activity, for use in inflammation and immunology (I&I) indications.
MedTech and Medical Devices
MMI’s Symani Surgical System Treats First Alzheimer’s Patient in Groundbreaking REMIND Study
MMI (Medical Microinstruments, Inc.), a robotics company dedicated to expanding treatment options and improving outcomes for patients with complex conditions, announced completion of the first robotic-assisted procedure in REMIND, its U.S. Investigational Device Exemption (IDE) Study, evaluating microsurgical intervention for neurodegenerative disease. Performed by a multidisciplinary team at Baptist Health in Jacksonville, FL, the case represents the study’s inaugural procedure and first patient enrollment – a participant with moderate Alzheimer’s disease with confirmed abnormalities in their deep cervical lymph node (dCLN) region.
OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale
OptimizeRx Corp., a provider of healthcare technology solutions helping life sciences companies reach and engage healthcare providers (HCPs) and patients at the most important decision points, announced the launch of a new programmatic connection point between OptimizeRx’s proprietary EHR network and DSPs, enabling media buyers to activate scalable, point of care campaigns within their existing programmatic workflows. This launch also opens up new access for OptimizeRx to the programmatic market, estimated at 90% of the total U.S. digital display ad spend across all industries.
Ballad Health invests $15 million to expand robotic-assisted surgery, earns national accreditation for quality and surgical excellence
Ballad Health was awarded Network of Excellence accreditation in robotic surgery by Surgical Review Corporation (SRC), honoring systemwide excellence in patient safety, surgical outcomes and clinical consistency. The national recognition coincides with a $15 million investment to expand robotic-assisted surgery across the region, bringing the program to additional rural hospitals. Ballad Health also recognized multiple surgeons who have achieved SRC Master Surgeon accreditation, underscoring a sustained commitment to the highest standards of surgical quality across the Appalachian Highlands.
ImpediMed Broadens Breast Cancer Survivorship Monitoring with the SOZO® Digital Health Platform at ASBrS 2026
ImpediMed, a leader in medical technologies to clinically monitor and manage fluid and body composition, announced an expanded clinical vision for breast cancer survivorship care at the American Society of Breast Surgeons (ASBrS) 2026 Annual Meeting. ImpediMed is showcasing its SOZO Digital Health Platform with L-Dex® and BodyComp™ Analysis as an integrated fluid and body composition monitoring tool for survivorship.
AiZtech Labs Launches iSelfie BioSignals to Help Providers Improve Triage, Reduce Intake Friction, and Assess Patients Earlier
AiZtech Labs has launched iSelfie BioSignals in the U.S. healthcare market, introducing a smartphone-based platform that helps providers and care organizations assess patients earlier and reduce friction in triage and intake workflows. Using a standard selfie-camera interaction to detect digital biomarkers from the eye and surrounding skin, iSelfie BioSignals is designed to generate clinically meaningful measurements in approved settings that can help care teams prioritize patients faster, act earlier, and reduce dependence on device-heavy front-end workflows.
Cardioline Acquires Cardios
Cardioline, a globally recognized leader in cardiac diagnostics and a pioneer in Telecardiology, delivering connected, remote cardiac care solutions to clinicians and patients across more than 85 countries, announced the successful acquisition of Cardios (São Paulo, Brazil) from Halma. Cardios is a highly respected innovator in Holter monitoring and ambulatory blood pressure monitoring (ABPM) with a decades-long track record of clinical reliability in Brazil. The transaction, supported by ARCHIMED, marks a transformative milestone for both organizations, accelerating Cardioline’s telecardiology strategy and signaling a new chapter in the advancement of comprehensive, connected, and patient-centered cardiac diagnostics worldwide.
Banner Health becomes world leader in total artificial heart
Banner Health announced it has reached a major milestone completing more than 50 total artificial heart implantation procedures, more than any center worldwide since 2022. This achievement solidifies the nonprofit health system’s position as the global leader in total artificial heart technology, with expertise that extends beyond patient care to consulting with medical centers and device manufacturers around the world on patient selection, surgery and management of total artificial hearts. Banner Health’s total artificial heart program is currently one of the busiest in the world.
BIOTRONIK Announces FDA Approval for Acticor Sky and Rivacor Sky ICD and CRT-D Systems
BIOTRONIK, a global leader in cardiovascular medical technology, announced U.S. Food and Drug Administration (FDA) approval of its Acticor Sky and Rivacor Sky implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) systems. The approval expands BIOTRONIK’s cardiac rhythm portfolio with novel technologies designed to support physiology-driven therapies and improve day-to-day clinical workflows.
Freudenberg Medical Launches CleanAssure, an ISO Class 5 Controlled Cleanroom for Sterile Single-use Assemblies
Freudenberg Medical, a global contract design and manufacturing partner to the medical device and biopharma industry, announced the launch of CleanAssure™, a new ISO Class 5 controlled cleanroom designed to deliver clean and sterile single-use assemblies for biopharmaceutical customers.
Clinical Studies and Trials
Robocath completes first-in-human study enrollment for next-generation PCI robotic system
Robocath has completed patient enrollment in its First-In-Human (FIH) clinical study evaluating the company’s next-generation robotic system for percutaneous coronary interventions (PCI), marking a significant milestone in robotic-assisted interventional cardiology.
CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population
CVRx, Inc., a medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced the enrollment of the first patient in the landmark BENEFIT-HF trial at North Central Heart – a division of the Avera Heart Hospital, in Sioux Falls, S.D. by Dr. Orvar Jonsson.
Events
Bio-IT World Conference & Expo
When: May 19-21, 2026
Where: Boston, MA
Event Page
Hashtag: #BioITExpo
Register for this event.
The Bio-IT World Conference & Expo is the premier global event showcasing technologies and analytic approaches that solve problems, accelerate science, and drive the future of precision medicine. Now in its 25th year, the event convenes more than 2,900 leaders from biopharma, clinical research, healthcare, informatics, and technology to exchange ideas, showcase solutions, and spark collaborations that push the boundaries of biomedical research, drug discovery, and patient outcomes. Spanning 200+ sessions—including plenary keynotes, symposia, technical workshops, and hands-on demonstrations—Bio-IT World offers unmatched opportunities to explore the tools, platforms, and strategies redefining R&D and clinical care. From AI, generative AI, and machine learning to multimodal and real-world data strategies, FAIR/Open Source practices, pilot programs, new product launches, and biotech investment trends, attendees engage in transformative conversations that translate innovation into measurable value.
BIO International Convention
When: June 22-25, 2026
Where: San Diego, CA
Event Page
Register for this event.
Touted as the largest and most comprehensive event for biotechnology, the BIO International Convention includes the full ecosystem of biotech. Organizers explain that it is the place to reconnect with your “why”—or the place where you remember your goal is to improve lives. It also fosters building relationships and making connections through their proprietary BIO Partnering meeting-scheduling platform, which is available with the Premier Access registrations.